POTENZA, Leonardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.238
AS - Asia 11.084
EU - Europa 10.247
SA - Sud America 1.554
AF - Africa 273
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 27
Totale 48.452
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.859
SG - Singapore 3.326
GB - Regno Unito 2.902
CN - Cina 2.770
IT - Italia 2.093
HK - Hong Kong 1.808
VN - Vietnam 1.292
BR - Brasile 1.167
SE - Svezia 1.163
DE - Germania 937
FI - Finlandia 794
RU - Federazione Russa 564
FR - Francia 458
UA - Ucraina 389
KR - Corea 296
TR - Turchia 288
IN - India 271
ID - Indonesia 227
CA - Canada 185
BG - Bulgaria 167
BD - Bangladesh 131
NL - Olanda 130
AR - Argentina 111
MX - Messico 102
IQ - Iraq 95
JP - Giappone 88
ES - Italia 77
BE - Belgio 71
ZA - Sudafrica 71
PL - Polonia 70
IE - Irlanda 68
CZ - Repubblica Ceca 67
EC - Ecuador 66
PK - Pakistan 62
AT - Austria 61
AE - Emirati Arabi Uniti 59
CO - Colombia 56
PH - Filippine 45
LT - Lituania 44
CL - Cile 43
MA - Marocco 43
KE - Kenya 40
VE - Venezuela 39
MY - Malesia 34
UZ - Uzbekistan 33
SA - Arabia Saudita 29
JO - Giordania 28
PY - Paraguay 27
AU - Australia 26
DZ - Algeria 26
IR - Iran 26
AZ - Azerbaigian 23
BZ - Belize 22
EG - Egitto 22
RO - Romania 22
CH - Svizzera 20
EU - Europa 18
CR - Costa Rica 17
TN - Tunisia 17
AL - Albania 16
DK - Danimarca 16
PT - Portogallo 16
SK - Slovacchia (Repubblica Slovacca) 16
UY - Uruguay 16
IL - Israele 15
TW - Taiwan 15
BO - Bolivia 14
NP - Nepal 14
PE - Perù 13
SI - Slovenia 13
JM - Giamaica 12
OM - Oman 12
RS - Serbia 12
TH - Thailandia 11
GR - Grecia 10
PS - Palestinian Territory 10
BH - Bahrain 9
DO - Repubblica Dominicana 9
KG - Kirghizistan 8
KZ - Kazakistan 8
MK - Macedonia 8
NG - Nigeria 8
BN - Brunei Darussalam 7
BY - Bielorussia 7
CY - Cipro 7
LB - Libano 7
NO - Norvegia 7
EE - Estonia 6
ET - Etiopia 6
MD - Moldavia 6
NI - Nicaragua 6
PA - Panama 6
QA - Qatar 6
SN - Senegal 6
XK - ???statistics.table.value.countryCode.XK??? 6
AM - Armenia 5
AO - Angola 5
GT - Guatemala 5
LU - Lussemburgo 5
SY - Repubblica araba siriana 5
Totale 48.374
Salva come PNG Salva come JPEG
Città #
Ashburn 2.639
Fairfield 2.609
Santa Clara 2.199
Singapore 2.061
Southend 1.881
Hong Kong 1.791
Woodbridge 1.504
Chandler 1.316
Houston 1.267
Seattle 1.022
San Jose 897
Ann Arbor 885
Wilmington 847
Cambridge 827
Hefei 791
Nyköping 660
Jacksonville 654
Helsinki 603
Dearborn 589
London 527
Beijing 524
Chicago 459
Modena 428
Los Angeles 420
Ho Chi Minh City 415
New York 383
Hanoi 294
Council Bluffs 292
Seoul 272
The Dalles 264
San Diego 247
Munich 196
Milan 182
Salt Lake City 179
Princeton 176
Jakarta 174
Bologna 165
Lauterbourg 163
Sofia 163
Buffalo 152
Izmir 135
Eugene 134
Moscow 134
Fremont 124
Shanghai 121
Dallas 106
Bremen 102
São Paulo 95
Orem 89
Frankfurt am Main 78
Tampa 76
Boardman 73
Da Nang 72
Elk Grove Village 69
Redwood City 66
Rome 65
Des Moines 61
Phoenix 61
Tokyo 61
Dublin 60
Brussels 55
Nuremberg 55
Atlanta 53
Toronto 53
Turku 53
Warsaw 53
Brooklyn 52
Columbus 52
Chennai 51
Haiphong 50
Montreal 49
Denver 48
Reggio Emilia 48
Guangzhou 39
Amsterdam 38
Boston 38
Dong Ket 38
Nairobi 38
Parma 37
Stockholm 37
Vienna 36
Baghdad 35
Mexico City 35
Sterling 35
Johannesburg 34
Miami 34
Kent 33
Las Vegas 33
Ottawa 33
Redondo Beach 33
Lancaster 32
Rio de Janeiro 31
Brno 29
Manchester 29
San Francisco 29
Tashkent 29
Kilburn 28
Paris 28
Belo Horizonte 26
Detroit 26
Totale 34.464
Salva come PNG Salva come JPEG
Nome #
HHV-6A in syncytial giant-cell hepatitis 460
Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation 460
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 441
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 417
Kaposi's sarcoma after liver transplantation 406
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 398
B cells and herpesviruses: a model of lymphoproliferation 392
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 390
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 388
Helicobacter pylori infection andchronic immune thrombocytopenic purpura: long-term results of bacteriumeradication and association with bacterium virulence profiles 387
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 366
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 364
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 360
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 355
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling 353
Acute appendicitis in adult neutropenic patients with hematologic malignancies 352
Selective inhibition of PI3Kγ affects survival and proliferation of chronic lymphocytic leukemia B cells 351
Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. 350
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 349
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 347
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 344
Early versus delayed palliative/supportive care in advanced cancer: An observational study 343
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 342
Assessment of aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis 341
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 340
Leukaemic pulmonary infiltrates in adult acute myeloid leukaemia: a high-resolution computerized tomography study 339
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 339
Translational challenges of human herpesvirus 6 chromosomal integration. 336
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma 334
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 332
An unusual case of splenomegaly and increased lactate dehydrogenase heralding acute myeloid leukemia with eosinophilia and RUNX1-MECOM fusion transcripts 330
Mucorales-specific T cells in patients with hematologic malignancies 326
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 324
Immunophenotypic Profile and Clinical Outcome of Monoclonal B-cell Lymphocytosis in Kidney Transplantation 321
Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates 320
Ocular involvement as first sign of isolated CNS relapse in diffuse large B-cell lymphoma 319
A t(11;20)(p15;q11) may identify a subset of nontherapy-related acute myelocytic leukemia 317
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 316
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 316
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 315
Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura. 313
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 312
Rhodotorula infection in haematological patient: risk factors and outcome 310
T-cell large granular lymphocyte leukemia in solid organ transplant recipients: case series and review of the literature 309
Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells 307
Isolated extramedullary relapse after autologous bone marrow transplantation for acute myeloid leukemia: Case report and review of the literature 306
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 305
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 304
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 302
A possible role for low-dose cyclosporine in refractory immune thrombocytopenic purpura. 301
Parvoviruses in blood donors and transplant patients, Italy 301
Cytarabine-related lung infiltrates on high resolution computerized tomography: a possible complication with benign outcome in leukemic patients. 300
Monoclonal Gammopathy of Undetermined Significance After Kidney Transplantation: Single-Center Experience 299
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 299
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 294
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 291
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 291
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 289
Herpes simplex virus pneumonia during standard induction chemotherapy for acute leukemia: case report and review of literature. 288
invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 286
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) 286
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 286
Clinical differences in sarcoidosis patients with and without lymphoma: a single-center retrospective cohort analysis. 286
Epstein-Barr virusassociated pneumonia in an adult patient with severe aplastic anaemia: resolutionafter the transient withdrawal of cyclosporine. 283
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 281
Breast Location for De Novo Extramedullary Myeloid Sarcoma 281
Investigating the association between physicians self-efficacy regarding communication skills and risk of “burnout” 281
Diagnosis of aspergillosis: Role of proteomics 280
Different semantic and affective meaning of the words associated to physical and social pain in cancer patients on early palliative/supportive care and in healthy, pain-free individuals 280
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 277
'Gloves and socks' papular purpuric syndrome following primary infection with parvovirus B19: a link between dermatologists and haematologists 276
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib 276
Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis 275
Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections 275
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 274
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir 271
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 271
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 270
Multicenter Prospective Study for Laboratory Diagnosis of HHV8 Infection in Solid Organ Donors and Transplant Recipients and Evaluation of the Clinical Impact After Transplantation 268
"Metodo per la diagnosi e/o il monitoraggio della mucormicosi" - "Method for the diagnosis of and/or monitoring mucormycosis" 267
Lenalidomide in chronic lymphocytic leukemia: The present and future in the era of tyrosine kinase inhibitors 265
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 263
Pain and emotional distress in leukemia patients at diagnosis. 261
Myocardial ischemia in a patient with acute lymphoblastic leukemia during L-asparaginase therapy 261
The importance of cytogenetic and molecular analyses in eosinophilia-associated myeloproliferative neoplasms: an unusual case with normal karyotype and TNIP1- PDGFRB rearrangement and overview of PDGFRB partner genes 260
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 259
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 259
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 258
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 258
Prevalence of Human Herpesvirus-6 Chromosomal Integration (CIHHV-6) in Italian Solid Organ and Allogeneic Stem Cell Transplant Patients 257
BK virus infection and neurologic dysfunctions in a patient with lymphoma treated with chemotherapy and rituximab 256
Safety profile of Erwinia asparaginase treatment in adults with newly diagnosed acute lymphoblastic leukemia: a retrospective monocenter study 253
Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms 251
BTK Inhibitors Impair Platelet-Mediated Antifungal Activity 250
How I treat HHV8/KSHV-related diseases in posttransplant patients. 247
Cardiac involvement in malignancies. Case 2. Right ventricular lesion as presenting feature of acute promyelocytic leukemia 247
Common Genetic Polymorphisms within NFκB-Related Genes and the Risk of Developing Invasive Aspergillosis 246
Immunity to polyomavirus BK infection: Immune monitoring to regulate the balance between risk of BKV nephropathy and induction of alloimmunity 245
Thrombotic complications associated with thalidomide in multiple myeloma: an old problem with new questions and quandaries in decision-making 244
Mixed warm and cold autoimmune hemolytic anemia: complete recovery after 2 courses of rituximab treatment 243
Totale 30.914
Salva come PNG Salva come JPEG
Categoria #
all - tutte 192.134
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 192.134
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.177 0 0 0 0 0 0 0 0 0 554 335 288
2021/20223.714 247 432 370 182 85 173 203 178 348 310 619 567
2022/20233.991 507 450 277 363 541 500 105 425 426 74 165 158
2023/20242.903 102 140 189 265 527 274 313 436 59 90 185 323
2024/20258.785 293 119 157 570 1.516 1.245 626 475 1.248 482 906 1.148
2025/202614.850 1.229 633 1.259 1.850 2.673 1.171 2.183 787 1.630 1.435 0 0
Totale 48.917